Innova Partnerships is pleased to announce that it has been appointed by Invest Northern Ireland to support the growth of exports to the rest of the UK by life and health science companies across the region for a three-year period.
Invest Northern Ireland is the economic development agency for Northern Ireland. They help businesses compete successfully in international markets through a variety of support mechanisms. During 2016/17, over £200m was invested in R&D and wider innovation and created an additional 5,900 new jobs.
Commenting, Innova Partnerships’ Chief Operating Officer, Joanne Hagerty said, “We are delighted to have the chance to mirror the success we have had in Scotland in Northern Ireland. Earlier this year the Northern Ireland Assembly committed…
Innova Partnerships is pleased to announce that its latest portfolio company, Vitamica Ltd, is a spin out from the University of Bristol.
The Company has been formed to commercialise the ground-breaking work of Dr Massimo Antognozzi, from the Department of Physics, who has used optical analysis of live bacteria to measure changes in their response to antibiotics. The technique has demonstrated a fast and accurate technique that can be used to assess antimicrobial resistance of bacteria. This will open up applications for personalised medicine and should help stem the over use of antibiotics.
The University of Bristol and Innova Partnerships worked together to evaluate the opportunity which led to the formation of the spin out. Over a period of 9 months Innova worked with…
Scottish based Biotangents Ltd are developing timely diagnostics to improve livestock welfare. Recently, the Company closed an equity financing round of £326,000 that will be used to progress their pen-side infectious disease test. The investment came from Kelvin Capital members and was supported by Innova Partnerships.
Commenting, Innova’s founder, Prof Steve Howell, said “The team at Biotangents have made significant progress over the last year and this investment will allow them to speed up product development.”
Biotangents CEO, Alan Hale, added “We have some exceptional individuals and founders, in Andy and Lina. Together, we are focussed on bringing to market cost-effective solutions to support livestock disease management and look forward to an exciting year ahead.”
We have a passion for commercialisation and believe the key to a successful partnership is getting to know the people behind the ideas. Our office is always open for a conversation. A lot can happen over a cup of coffee…